Landscape Capital Management L.L.C. Buys 85,834 Shares of Hims & Hers Health, Inc. $HIMS

Key Points

• Landscape Capital Management L.L.C. increased its stake in Hims & Hers Health by 43.3% in the first quarter, holding a total of 283,853 shares valued at approximately $8.4 million.
• Several institutional investors, including Corebridge Financial Inc. and FORA Capital LLC, significantly boosted their positions in Hims & Hers Health during the same quarter.
• Hims & Hers Health reported a quarterly earnings miss, with earnings of $0.17 per share against an estimate of $0.18, alongside a revenue of $544.83 million, below the consensus estimate of $550.06 million.

Landscape Capital Management L.L.C. raised its stake in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 43.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 283,853 shares of the company's stock after buying an additional 85,834 shares during the period. Hims & Hers Health comprises about 0.7% of Landscape Capital Management L.L.C.'s portfolio, making the stock its 12th biggest position. Landscape Capital Management L.L.C. owned 0.13% of Hims & Hers Health worth $8,388,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in the stock. OMERS ADMINISTRATION Corp bought a new stake in shares of Hims & Hers Health in the 1st quarter valued at about $1,421,000. Ieq Capital LLC grew its position in shares of Hims & Hers Health by 39.4% in the 1st quarter. Ieq Capital LLC now owns 57,361 shares of the company's stock valued at $1,695,000 after buying an additional 16,224 shares during the last quarter. FORA Capital LLC boosted its position in shares of Hims & Hers Health by 22.7% during the 1st quarter. FORA Capital LLC now owns 170,679 shares of the company's stock valued at $5,044,000 after purchasing an additional 31,540 shares in the last quarter. Corebridge Financial Inc. boosted its position in shares of Hims & Hers Health by 201.3% during the 1st quarter. Corebridge Financial Inc. now owns 304,591 shares of the company's stock valued at $9,001,000 after purchasing an additional 203,500 shares in the last quarter. Finally, Freedom Investment Management Inc. bought a new stake in shares of Hims & Hers Health during the 1st quarter valued at about $380,000. Institutional investors own 63.52% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on HIMS shares. Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Hims & Hers Health in a research report on Wednesday, May 7th. Morgan Stanley restated an "equal weight" rating and set a $40.00 target price on shares of Hims & Hers Health in a research report on Wednesday, June 11th. Zacks Research lowered Hims & Hers Health from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, August 19th. Needham & Company LLC restated a "hold" rating on shares of Hims & Hers Health in a research report on Tuesday, August 5th. Finally, Citigroup restated a "sell" rating on shares of Hims & Hers Health in a research report on Monday, June 23rd. Two analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Reduce" and an average price target of $38.92.

Insider Transactions at Hims & Hers Health

In other news, insider Michael Chi sold 17,102 shares of the stock in a transaction that occurred on Tuesday, June 17th. The stock was sold at an average price of $59.75, for a total value of $1,021,844.50. Following the completion of the sale, the insider directly owned 278,654 shares of the company's stock, valued at $16,649,576.50. This represents a 5.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Oluyemi Okupe sold 23,107 shares of the stock in a transaction that occurred on Monday, June 23rd. The stock was sold at an average price of $47.25, for a total value of $1,091,805.75. Following the completion of the sale, the chief financial officer directly owned 63,222 shares of the company's stock, valued at approximately $2,987,239.50. This trade represents a 26.77% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,383,847 shares of company stock worth $71,247,924 in the last three months. Insiders own 13.71% of the company's stock.

Hims & Hers Health Stock Down 2.8%

Shares of NYSE:HIMS opened at $44.07 on Thursday. The business's 50 day simple moving average is $50.76 and its two-hundred day simple moving average is $45.84. The firm has a market cap of $9.96 billion, a P/E ratio of 55.09, a PEG ratio of 3.06 and a beta of 2.08. The company has a debt-to-equity ratio of 1.72, a quick ratio of 4.46 and a current ratio of 4.98. Hims & Hers Health, Inc. has a 52-week low of $13.47 and a 52-week high of $72.98.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). The firm had revenue of $544.83 million during the quarter, compared to the consensus estimate of $550.06 million. Hims & Hers Health had a return on equity of 26.26% and a net margin of 9.63%.The firm's revenue was up 72.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.06 EPS. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, research analysts forecast that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Want to see what other hedge funds are holding HIMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hims & Hers Health, Inc. (NYSE:HIMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.